The Development Program. Promptly following receipt of the amount set forth in Section 2 below, Institution shall use diligent efforts to develop Invader(R) polymorphism and mRNA transcript assays described in the Protocol, subject to Company providing Institution the materials described in Exhibit B (collectively, the "Company Materials"). Upon completion of the Development Program with respect to each such particular assay, Institution agrees to provide Company with the number of assay determinations set forth in the Protocol for such particular assay, including enzyme, buffer and Invader probes for such analyte (collectively, the "Institution Materials"). Accordingly, Institution shall, after consultation with Company, direct and perform the Development Program in a professional and diligent manner, all in accordance with the Protocol and the terms of this Agreement.
Appears in 2 contracts
Sources: Research Agreement (Third Wave Technologies Inc /Wi), Research Agreement (Third Wave Technologies Inc /Wi)